Latest Stenocare News & Updates

See the latest news and media coverage for Stenocare. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Stenocare

Danish pharmaceutical medical cannabis supplier

stenocare.com
Headquarters
Kirke Værløse, Denmark
Founded year
2017
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Stenocare

In short: Stenocare reported record 2025 revenue of $7.0 million, achieved EBITDA breakeven in multiple quarters, and expanded through the CannGros acquisition.

Company announcements

  • Stenocare

    Stenocare delivers strong Q1 results

    Sales rose 15% to 3 million DKK with positive EBITDA and operating cash flow. Integration of CannGros strengthens market position. Expects growth and break-even in 2026.

  • Stenocare

    Stenocare publishes its Annual Report 2025

    The report highlights record year, strong sales growth, EBITDA improvement, and CannGros acquisition for 2026 break-even.

  • Stenocare

    Stenocare enters France for first-mover advantage

    Stenocare partners with ICMF and Movianto, submitting ASTRUM 10-10 oil dossier to French authorities. France expects medical cannabis legalization in 2026.

  • Stenocare

    Stenocare partners with WEECO Pharma in Germany

    They launch the new Astrum Oil brand to accelerate sales and patient reach. Rolf Steno and WEECO CEO Tony Schroeter shake hands.

Unlock all announcements with a

Media coverage

  • FinanzNachrichten

    Stenocare A/S: Interim report first quarter 2026

    STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which...

  • Økonomisk Ugebrev

    STENOCARE A/S publishes Annual Report 2025

    STENOCARE A/S published the annual report for 2025, which shows three quarters with positive EBITDA and a record net revenue of 7.0 million DKK, which is a...

  • Økonomisk Ugebrev

    Stenocare reached EBITDA breakeven in Q4

    Stenocare A/S announces its results for 2025. The year's net revenue rose to 7,021 t.kr. from 2,232 t.kr. in 2024. The year's EBITDA was -1,742 t.kr., but...

  • Økonomisk Ugebrev

    STENOCARE A/S acquires CannGros ApS and adds DKK 4-6 million in annual revenue and supports the goal of breaking even in 2026 | Economic Weekly

    Stenocare A/S has acquired CannGros ApS from DanCann Pharma A/S. This adds DKK 4-6 million in annual revenue. The acquisition supports Stenocare's goal of financial balance...

Unlock all articles with a

Never miss news about Stenocare

Track Stenocare and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Stenocare competitors & trending companies

Browse news for competitors to Stenocare and other trending companies.